These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17494015)

  • 1. Too much of a good thing.
    Tonks A
    BMJ; 2007 May; 334(7601):978-80. PubMed ID: 17494015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia of chronic kidney disease: when normalcy becomes undesirable.
    Demirjian SG; Nurko S
    Cleve Clin J Med; 2008 May; 75(5):353-6. PubMed ID: 18556877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA
    Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of severe hyperparathyroidism and its influence on anaemia in end-stage renal failure.
    Argilés A; Mourad G; Lorho R; Kerr PG; Flavier JL; Canaud B; Mion CM
    Nephrol Dial Transplant; 1994; 9(12):1809-12. PubMed ID: 7708272
    [No Abstract]   [Full Text] [Related]  

  • 6. New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.
    Steensma DP
    J Support Oncol; 2007; 5(10):471-3. PubMed ID: 18240668
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
    [No Abstract]   [Full Text] [Related]  

  • 8. European best practice guidelines 17-18: adverse effects.
    Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Carveth BG; Thompson K
    Nephrol Dial Transplant; 2000; 15 Suppl 4():51-6. PubMed ID: 11052149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anemia and renal failure: efficacy of its control].
    Fort J
    Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Blood will have blood'.
    Mandell BF
    Cleve Clin J Med; 2008 May; 75(5):327. PubMed ID: 18556873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variability of the hemoglobin level: each patient is unique].
    Zaoui P; Deray G; Ortiz JP; Rostaing L
    Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H1-4. PubMed ID: 21371677
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation and application of anemia clinical practice guidelines.
    Winn RJ; Muller RJ; Cella D
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-33-9. PubMed ID: 23573552
    [No Abstract]   [Full Text] [Related]  

  • 13. I want to be at least a 10: the impact of changes in metrics and labeling for ESAs.
    Hartwell L
    Nephrol News Issues; 2012 Jun; 26(7):12-3. PubMed ID: 22928240
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic use of erythropoietin in dermatooncology.
    Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemoglobin targets: we were wrong, time to move on.
    Strippoli GF; Tognoni G; Navaneethan SD; Nicolucci A; Craig JC
    Lancet; 2007 Feb; 369(9559):346-50. PubMed ID: 17276756
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy.
    Chan AT; Leung WT; Lin J; Yeo W; Johnson PJ
    Clin Oncol (R Coll Radiol); 1995; 7(4):272. PubMed ID: 8845332
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of erythropoietin on systolic and diastolic left ventricular function in chronic renal failure with anemia.
    Ozakgun R; Paydas S; Demirtas M; Sagliker Y
    Nephron; 1995; 71(1):103-4. PubMed ID: 8538829
    [No Abstract]   [Full Text] [Related]  

  • 19. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
    Coyne DW
    Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.